about
Bortezomib for the treatment of multiple myelomaBisphosphonates in multiple myeloma: a network meta-analysisPhysiotherapy versus placebo or no intervention in Parkinson's diseaseMaintenance therapies for multiple myelomaPhysiotherapy versus placebo or no intervention in Parkinson's diseasePhysiotherapy versus placebo or no intervention in Parkinson's diseaseBortezomib for the treatment of multiple myelomaEvaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complicationsBisphosphonates in multiple myelomaDopamine agonist therapy in early Parkinson's diseaseEvaluation of the efficacy and safety of adjunct treatment to levodopa therapy in Parkinson's disease patients with motor complicationsFirst-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myelomaEarly versus deferred treatment for early stage multiple myelomaReticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapyRAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: ...
P50
Q24185881-3667E0BE-BD7C-43C8-8430-6C04892C9CA6Q24197839-3E2CF06A-F8D8-48A1-AEF1-258BB2C90877Q24198167-75FAB602-092E-49ED-8CF4-7681E736C3F2Q24198800-331E92BE-F8FE-4763-B1C8-D24D0AB519B3Q24201362-9709EFCF-1E12-480A-BF0D-BDF6DCCBC0C6Q24202026-901C2355-6770-4DC1-A843-188BE44D67BAQ24202774-34CD5E76-98AB-4134-ACC8-A9A324BD06B4Q24234273-5D19AB78-55CF-481E-BF38-8763CF288834Q24236776-F9CEA5CF-9110-4B41-AC70-BA979A1BA43AQ24243105-2DCC21B1-64A2-47B1-A00C-89AD87E86AA2Q24243535-696795CF-4CA7-4AFD-A249-E1C1B16EDAADQ24243542-E6C82524-61BF-43D9-8CA3-EC68843E8D47Q24250249-3B0F07DF-88BF-4043-8F61-75F8F7B3C744Q24631288-38AD2E8A-D44E-40EC-8A99-228F1A44DF72Q27824840-129CA889-87EE-4917-8F7E-B4573A30D106Q27856359-0AA926DA-DA5E-4E8F-8B66-31CB494B9BA1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Keith Wheatley
@ast
Keith Wheatley
@en
Keith Wheatley
@es
Keith Wheatley
@nl
Keith Wheatley
@sl
type
label
Keith Wheatley
@ast
Keith Wheatley
@en
Keith Wheatley
@es
Keith Wheatley
@nl
Keith Wheatley
@sl
prefLabel
Keith Wheatley
@ast
Keith Wheatley
@en
Keith Wheatley
@es
Keith Wheatley
@nl
Keith Wheatley
@sl